Non-invasive risk scores for prediction of type 2 diabetes (EPIC-InterAct): A validation of existing models

The Lancet Diabetes and Endocrinology

Volumn 2, Issue 1, 2014, Pages 19-29

  Kengne, Andre Pascal ^a,b,c   Beulens, Joline W J ^a   Peelen, Linda M ^a   Moons, Karel G M ^a   van der Schouw, Yvonne T ^a   Schulze, Matthias B ^d   Spijkerman, Annemieke M W ^e   Griffin, Simon J ^f   Grobbee, Diederick E ^a   Palla, Luigi ^f   Tormo, Maria Jose ^g   Arriola, Larraitz ^h   Barengo, Noël C ⁱ   Barricarte, Aurelio ^j   Boeing, Heiner ^d   Bonet, Catalina ^k   Clavel Chapelon, Françoise ^l   Dartois, Laureen ^l   Fagherazzi, Guy ^l   Franks, Paul W ^m   Huerta, José María ^g   Kaaks, Rudolf ⁿ   Key, Timothy J ^o   Khaw, Kay Tee ^p   Li, Kuanrong ⁿ   Mühlenbruch, Kristin ^d   Nilsson, Peter M ^m   Overvad, Kim ^q   Overvad, Thure F ^r   Palli, Domenico ^s   Panico, Salvatore ^t   Quirós, J Ramón ^u   Rolandsson, Olov ^v   Roswall, Nina ^w   Sacerdote, Carlotta ^x   Sánchez, María José ^y   Slimani, Nadia ^z   Tagliabue, Giovanna ^aa   Tjønneland, Anne ^c   Tumino, Rosario ^ab   van der A, Daphne L ^e   Forouhi, Nita G ^f   Sharp, Stephen J ^f   Langenberg, Claudia ^f   Riboli, Elio ^ac   Wareham, Nicholas J ^f   more..

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

^c GEORGE INSTITUTE FOR GLOBAL HEALTH   (Australia)

^d GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^e NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^f MRC EPIDEMIOLOGY UNIT   (United Kingdom)

^g DEPARTMENT OF EPIDEMIOLOGY   (Spain)

^h Basque Government   (Spain)

ⁱ UNIVERSITY OF HELSINKI   (Finland)

^j INSTITUTO DE SALUD PÚBLICA DE NAVARRA   (Spain)

^k CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^l CENTRE FOR RESEARCH IN EPIDEMIOLOGY AND POPULATION HEALTH   (France)

^m LUND UNIVERSITY   (Sweden)

ⁿ GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^o UNIVERSITY OF OXFORD   (United Kingdom)

^p UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^q AARHUS UNIVERSITY   (Denmark)

^r AALBORG UNIVERSITY HOSPITAL   (Denmark)

^s CANCER RESEARCH AND PREVENTION INSTITUTE ISPO   (Italy)

^t UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^u PUBLIC HEALTH DIRECTORATE   (Spain)

^v UMEÅ UNIVERSITY   (Sweden)

^w DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^x Center for Cancer Prevention   (Italy)

^y ANDALUSIAN SCHOOL OF PUBLIC HEALTH   (Spain)

^z INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^aa NATIONAL CANCER INSTITUTE   (Italy)

^ab Cancer Registry and Histopathology Unit   (Italy)

^ac IMPERIAL COLLEGE LONDON   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; ARTICLE; ATHEROSCLEROSIS RISK IN COMMUNITIES RISK SCORE; AUSTRALIAN TYPE 2 DIABETES RISK ASSESSMENT TOOL RISK SCORE; BODY MASS; CONTROLLED STUDY; DIABETES POPULATION RISK TOOL RISK SCORE; EPIDEMIOLOGICAL STUDY ON THE INSULIN RESISTANCE SYNDROME RISK SCORE; EUROPEAN INVESTIGATION INTO CANCER AND NUTRITION RISK SCORE; FEMALE; FINNISH DIABETES RISK SCORE; FINNISH DIABETES RISK SCORE SURVEY 4; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTION; PREDICTIVE VALUE; PRIORITY JOURNAL; QD SCORE; RISK ASSESSMENT; SCORING SYSTEM; VALIDATION STUDY; WAIST CIRCUMFERENCE; BIOLOGICAL MODEL; CAUCASIAN; COHORT ANALYSIS; DIABETES MELLITUS, TYPE 2; PROCEDURES; SEX DIFFERENCE;

AGE FACTORS; BODY MASS INDEX; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; RISK ASSESSMENT; SEX FACTORS; WAIST CIRCUMFERENCE;

EID: 84890159890     PISSN: 22138587     EISSN: None     Source Type: Journal    
DOI: 10.1016/S2213-8587(13)70103-7     Document Type: Article

References (44)

1. IDF Diabetes Atlas 2011, International Diabetes Federation, International Diabetes Federation, Brussels. 5th edn.
2. Li G, Zhang P, Wang J, et al. The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study. Lancet 2008, 371:1783-1789.
3. Gillies CL, Abrams KR, Lambert PC, et al. Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis. BMJ 2007, 334:299.
4. Noble D, Mathur R, Dent T, Meads C, Greenhalgh T Risk models and scores for type 2 diabetes: systematic review. BMJ 2011, 343:d7163.
5. Buijsse B, Simmons RK, Griffin SJ, Schulze MB Risk assessment tools for identifying individuals at risk of developing type 2 diabetes. Epidemiol Rev 2011, 33:46-62.
6. Lindstrom J, Tuomilehto J The diabetes risk score: a practical tool to predict type 2 diabetes risk. Diabetes Care 2003, 26:725-731.
7. Collins GS, Mallett S, Omar O, Yu LM Developing risk prediction models for type 2 diabetes: a systematic review of methodology and reporting. BMC Med 2011, 9:103.
8. Abbasi A, Peelen LM, Corpeleijn E, et al. Prediction models for risk of developing type 2 diabetes: systematic literature search and independent external validation study. BMJ 2012, 345:e5900.
9. Alberti KG, Zimmet P, Shaw J International Diabetes Federation: a consensus on Type 2 diabetes prevention. Diabet Med 2007, 24:451-463.
10. Paulweber B, Valensi P, Lindstrom J, et al. A European evidence-based guideline for the prevention of type 2 diabetes. Horm Metab Res 2010, 42(suppl 1):S3-36.
11. Langenberg C, Sharp S, Forouhi NG, et al. Design and cohort description of the InterAct Project: an examination of the interaction of genetic and lifestyle factors on the incidence of type 2 diabetes in the EPIC Study. Diabetologia 2011, 54:2272-2282.
12. Kaaks R, Slimani N, Riboli E Pilot phase studies on the accuracy of dietary intake measurements in the EPIC project: overall evaluation of results. European Prospective Investigation into Cancer and Nutrition. Int J Epidemiol 1997, 26(suppl 1):S26-S36.
13. Wareham NJ, Jakes RW, Rennie KL, et al. Validity and repeatability of a simple index derived from the short physical activity questionnaire used in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Public Health Nutr 2003, 6:407-413.
14. Chambless LE, Diao G Estimation of time-dependent area under the ROC curve for long-term risk prediction. Stat Med 2006, 25:3474-3486.
15. Hosmer DW, Lemeshow S Applied logistic regression 1989, Wiley, New York.
16. Rockhill B, Spiegelman D, Byrne C, Hunter DJ, Colditz GA Validation of the Gail et al model of breast cancer risk prediction and implications for chemoprevention. J Natl Cancer Inst 2001, 93:358-366.
17. Steyerberg EW, Vickers AJ, Cook NR, et al. Assessing the performance of prediction models: a framework for traditional and novel measures. Epidemiology 2010, 21:128-138.
18. Steyerberg EW Clinical prediction models: a practical approach to development, validation, and updating 2009, Springer, Rotterdam.
19. Janssen KJ, Vergouwe Y, Kalkman CJ, Grobbee DE, Moons KG A simple method to adjust clinical prediction models to local circumstances. Can J Anaesth 2009, 56:194-201.
20. Schmidt MI, Duncan BB, Bang H, et al. Identifying individuals at high risk for diabetes: The Atherosclerosis Risk in Communities study. Diabetes Care 2005, 28:2013-2018.
21. Kahn HS, Cheng YJ, Thompson TJ, Imperatore G, Gregg EW Two risk-scoring systems for predicting incident diabetes mellitus in US adults age 45 to 64 years. Ann Intern Med 2009, 150:741-751.
22. Chen L, Magliano DJ, Balkau B, et al. AUSDRISK: an Australian Type 2 Diabetes Risk Assessment Tool based on demographic, lifestyle and simple anthropometric measures. Med J Aust 2010, 192:197-202.
23. Griffin SJ, Little PS, Hales CN, Kinmonth AL, Wareham NJ Diabetes risk score: towards earlier detection of type 2 diabetes in general practice. Diabetes Metab Res Rev 2000, 16:164-171.
24. Balkau B, Lange C, Fezeu L, et al. Predicting diabetes: clinical, biological, and genetic approaches: data from the Epidemiological Study on the Insulin Resistance Syndrome (DESIR). Diabetes Care 2008, 31:2056-2061.
25. Rosella LC, Manuel DG, Burchill C, Stukel TA A population-based risk algorithm for the development of diabetes: development and validation of the Diabetes Population Risk Tool (DPoRT). J Epidemiol Community Health 2011, 65:613-620.
26. Wilson PW, Meigs JB, Sullival L, Fox CS, Nathan DM, D'Agostino RB Prediction of incident diabetes mellitus in middle-aged adults: the Framingham Offspring Study. Arch Intern Med 2007, 167:1068-1074.
27. Rathmann W, Kowall B, Heier M, et al. Prediction models for incident type 2 diabetes mellitus in the older population: KORA S4/F4 cohort study. Diabet Med 2010, 27:1116-1123.
28. Schulze MB, Hoffmann K, Boeing H, et al. An accurate risk score based on anthropometric, dietary, and lifestyle factors to predict the development of type 2 diabetes. Diabetes Care 2007, 30:510-515.
29. Hippisley-Cox J, Coupland C, Robson J, Sheikh A, Brindle P Predicting risk of type 2 diabetes in England and Wales: prospective derivation and validation of QDScore. BMJ 2009, 338:b880.
30. Mann DM, Bertoni AG, Shimbo D, et al. Comparative validity of 3 diabetes mellitus risk prediction scoring models in a multiethnic US cohort: the Multi-Ethnic Study of Atherosclerosis. Am J Epidemiol 2010, 171:980-988.
31. Collins GS, Altman DG External validation of QDSCORE(R) for predicting the 10-year risk of developing type 2 diabetes. Diabet Med 2011, 28:599-607.
32. Lin JW, Chang YC, Li HY, et al. Cross-sectional validation of diabetes risk scores for predicting diabetes, metabolic syndrome, and chronic kidney disease in Taiwanese. Diabetes Care 2009, 32:2294-2296.
33. Schmid R, Vollenweider P, Waeber G, Marques-Vidal P Estimating the risk of developing type 2 diabetes: a comparison of several risk scores: the Cohorte Lausannoise study. Diabetes Care 2011, 34:1863-1868.
34. Schmid R, Vollenweider P, Bastardot F, Waeber G, Marques-Vidal P Validation of 7 type 2 diabetes mellitus risk scores in a population-based cohort: CoLaus Study. Arch Intern Med 2012, 172:188-189.
35. Alssema M, Vistisen D, Heymans MW, et al. The Evaluation of Screening and Early Detection Strategies for Type 2 Diabetes and Impaired Glucose Tolerance (DETECT-2) update of the Finnish diabetes risk score for prediction of incident type 2 diabetes. Diabetologia 2011, 54:1004-1012.
36. Rahman M, Simmons RK, Harding AH, Wareham NJ, Griffin SJ A simple risk score identifies individuals at high risk of developing type 2 diabetes: a prospective cohort study. Fam Pract 2008, 25:191-196.
37. Vazquez G, Duval S, Jacobs DR, Silventoinen K Comparison of body mass index, waist circumference, and waist/hip ratio in predicting incident diabetes: a meta-analysis. Epidemiol Rev 2007, 29:115-128.
38. Abdullah A, Peeters A, de Courten M, Stoelwinder J The magnitude of association between overweight and obesity and the risk of diabetes: a meta-analysis of prospective cohort studies. Diabetes Res Clin Pract 2010, 89:309-319.
39. Abbasi A, Corpeleijn E, Peelen LM, et al. External validation of the KORA S4/F4 prediction models for the risk of developing type 2 diabetes in older adults: the PREVEND study. Eur J Epidemiol 2012, 27:47-52.
40. Spijkerman A, Griffin S, Dekker J, Nijpels G, Wareham NJ What is the risk of mortality for people who are screen positive in a diabetes screening programme but who do not have diabetes on biochemical testing? Diabetes screening programmes from a public health perspective. J Med Screen 2002, 9:187-190.
41. Wareham NJ, Griffin SJ Risk scores for predicting type 2 diabetes: comparing axes and spades. Diabetologia 2011, 54:994-995.
42. Uusitupa M, Tuomilehto J, Puska P Are we really active in the prevention of obesity and type 2 diabetes at the community level?. Nutr Metab Cardiovasc Dis 2011, 21:380-389.
43. Saaristo T, Moilanen L, Korpi-Hyovalti E, et al. Lifestyle intervention for prevention of type 2 diabetes in primary health care: one-year follow-up of the Finnish National Diabetes Prevention Program (FIN-D2D). Diabetes Care 2010, 33:2146-2151.
44. Janssen KJ, Donders AR, Harrell FE, et al. Missing covariate data in medical research: to impute is better than to ignore. J Clin Epidemiol 2010, 63:721-727.